Accessibility Menu
 
Blonder Tongue Laboratories logo

Blonder Tongue Laboratories

(OTC) BDRL

Current PriceN/A
Market CapN/A
Since IPO (1995)-100%
5 Year-100%
1 Year-92%
1 Month-44%

Blonder Tongue Laboratories Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$11.44M

Net Income (TTM)

$1.32M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

BDRL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Blonder Tongue Laboratories

Industry

Communications Equipment

Employees

67

CEO

Robert J. Pallé, Jr.

Headquarters

Old Bridge, NJ 08857, US

BDRL Financials

Key Financial Metrics (TTM)

Gross Margin

33%

Operating Margin

-6%

Net Income Margin

-14%

Return on Equity

42%

Return on Capital

-14%

Return on Assets

-9%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$3.71M

Operating Income

$682.00K

EBITDA

$447.00K

Operating Cash Flow

$1.04M

Capital Expenditure

$4.00K

Free Cash Flow

$1.03M

Cash & ST Invst.

$33.00K

Total Debt

$8.14M

Blonder Tongue Laboratories Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$2.92M

+11.2%

Gross Profit

$1.01M

-2.0%

Gross Margin

34.50%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

67

N/A

Net Income

$314.00K

-30.8%

EBITDA

$124.00K

-36.1%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Net Cash

$8.08M

+10.5%

Accounts Receivable

$1.66M

+7.5%

Inventory

$1.95M

-37.3%

Long Term Debt

$4.72M

-10.6%

Short Term Debt

$3.45M

-8.8%

Return on Assets

-8.60%

N/A

Return on Invested Capital

-13.84%

N/A

Free Cash Flow

$95.00K

-22.8%

Operating Cash Flow

$177.00K

+39.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WGNRWegener Corporation
$0.01+2.29%
VRTCVeritec, Inc.
$0.00+0.00%
UBMRFUrbanimmersive Inc.
$0.00+0.00%
DLTIDLT Resolution Inc.
$1.09-2.68%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$9.30+3.02%
NOKNokia
$13.44+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.22+0.01%
NCLHNorwegian Cruise Line
$17.12-0.09%

Questions About BDRL

What is the current price of Blonder Tongue Laboratories?

Blonder Tongue Laboratories is trading at N/A per share.

What is the 52-week range for Blonder Tongue Laboratories?

Over the past 52 weeks, Blonder Tongue Laboratories has traded between N/A and N/A.

How much debt does Blonder Tongue Laboratories have?

As of the most recent reporting period, Blonder Tongue Laboratories reported total debt of $8.17M.

How much cash does Blonder Tongue Laboratories have on hand?

Blonder Tongue Laboratories reported $93,000 in cash and cash equivalents in its most recent financial results.

What is Blonder Tongue Laboratories’s dividend yield?

Blonder Tongue Laboratories does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.